True to its roots, Allergan cuts Exicure hair deal; bid SNAgs big back-end terms Nov. 15, 2019 By Randy Osborne No Comments CEO David Giljohann said the first indication in Exicure Inc.'s deal with Allergan plc is antigenic alopecia, but his firm doesn't "have anything else to disclose yet" about other hair loss diseases that the pact will include.Read More